Joint and soft-tissue injections in rehabilitation inpatients taking direct oral anticoagulantsNord, Hunter M.a; Journeay, W. Shaneb,,c; Lipson, David M.b,,cInternational Journal of Rehabilitation Research: June 2019 - Volume 42 - Issue 2 - p 187–189 doi: 10.1097/MRR.0000000000000330 Brief Research Reports Buy Abstract Author InformationAuthors Article MetricsMetrics The risk for complications associated with joint and soft-tissue injections in patients taking direct oral anticoagulants (DOACs) is not fully understood. In this retrospective evaluation of 445 inpatients in a rehabilitation hospital who received corticosteroid injections, complications were compared in patients on DOACs with those who were not. After a review of all injections, no adverse events of significant bleeding (intra-articular or extra-articular) were observed. These findings suggest no substantial increase in adverse events associated with the use of DOACs when performing joint and soft-tissue injection procedures in inpatient rehabilitation setting. aDepartment of Kinesiology, McMaster University bProvidence Healthcare cDepartment of Medicine, Division of Physical Medicine and Rehabilitation, University of Toronto, Ontario, Canada Received 26 September 2018 Accepted 11 November 2018 Correspondence to David Lipson, MD, FRCPC, Providence Healthcare, 3276 St Clair Avenue, East Toronto, ON, Canada M1L 1W1 Tel: +1 416 285 3619; fax: +1 416 285 3764; e-mail: firstname.lastname@example.org Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.